Response to: norepinephrine formulation for equivalent vasopressive score.
作者信息
Kotani Yuki, Landoni Giovanni, Belletti Alessandro, Khanna Ashish K
机构信息
Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.
School of Medicine, Vita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy.
出版信息
Crit Care. 2023 Mar 28;27(1):125. doi: 10.1186/s13054-023-04404-x.
Abstract
摘要
相似文献
1
Response to: norepinephrine formulation for equivalent vasopressive score.对：等效血管升压评分的去甲肾上腺素制剂的反应。
Crit Care. 2023 Mar 28;27(1):125. doi: 10.1186/s13054-023-04404-x.
2
Norepinephrine formulation for equivalent vasopressive score.用于等效血管升压评分的去甲肾上腺素制剂。
Crit Care. 2023 Feb 16;27(1):62. doi: 10.1186/s13054-023-04354-4.
3
An updated "norepinephrine equivalent" score in intensive care as a marker of shock severity.在重症监护中，更新的“去甲肾上腺素等效评分”作为休克严重程度的标志物。
Crit Care. 2023 Jan 20;27(1):29. doi: 10.1186/s13054-023-04322-y.
4
Vasopressor dosing in septic shock.感染性休克中的血管活性药物剂量
Crit Care Med. 2013 Dec;41(12):e483-4. doi: 10.1097/CCM.0b013e3182916fe7.
5
The authors reply.作者回复。
Crit Care Med. 2013 Dec;41(12):e484. doi: 10.1097/CCM.0000000000000015.
6
Less is more: catecholamine-sparing strategies in septic shock.少即是多：脓毒症休克中的儿茶酚胺节约策略
Intensive Care Med. 2019 Dec;45(12):1810-1812. doi: 10.1007/s00134-019-05770-3. Epub 2019 Sep 13.
7
Outcomes Associated With Norepinephrine Use Among Cardiac Intensive Care Unit Patients with Severe Shock.去甲肾上腺素在重症监护病房严重休克患者中的应用相关结果。
Shock. 2021 Oct 1;56(4):522-528. doi: 10.1097/SHK.0000000000001767.
8
Norepinephrine in septic shock.脓毒症休克中的去甲肾上腺素
Intensive Care Med. 2019 May;45(5):687-689. doi: 10.1007/s00134-018-5499-8. Epub 2019 Jan 10.
9
Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature.优化感染性休克中的平均动脉压：对文献的批判性重新评估。
Crit Care. 2015 Mar 10;19(1):101. doi: 10.1186/s13054-015-0794-z.
10
Comment on "A comparison of epinephrine and norepinephrine in critically Ill patients".关于“危重症患者肾上腺素与去甲肾上腺素的比较”的评论
Intensive Care Med. 2009 Jul;35(7):1310; author reply 1311. doi: 10.1007/s00134-009-1492-6. Epub 2009 Apr 15.
引用本文的文献
1
Norepinephrine pharmacolexicology: a chronological review of dose reporting and the implications of salt formulations.去甲肾上腺素药理学：剂量报告的时间顺序回顾及盐制剂的影响
Intensive Care Med. 2025 Sep;51(9):1664-1673. doi: 10.1007/s00134-025-08053-2. Epub 2025 Jul 29.
2
Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study.脓毒性休克中精氨酸血管加压素辅助去甲肾上腺素的血流动力学效应：一项前瞻性多中心注册研究的见解
Ann Intensive Care. 2025 Apr 29;15(1):59. doi: 10.1186/s13613-025-01472-w.
3
Haemodynamic management of septic shock.脓毒性休克的血流动力学管理
Burns Trauma. 2025 Jan 15;13:tkae081. doi: 10.1093/burnst/tkae081. eCollection 2025.
4
Vasopressin in Sepsis and Other Shock States: State of the Art.血管加压素在脓毒症及其他休克状态中的应用：最新进展
J Pers Med. 2023 Oct 29;13(11):1548. doi: 10.3390/jpm13111548.
本文引用的文献
1
Norepinephrine formulation for equivalent vasopressive score.用于等效血管升压评分的去甲肾上腺素制剂。
Crit Care. 2023 Feb 16;27(1):62. doi: 10.1186/s13054-023-04354-4.
2
An updated "norepinephrine equivalent" score in intensive care as a marker of shock severity.在重症监护中，更新的“去甲肾上腺素等效评分”作为休克严重程度的标志物。
Crit Care. 2023 Jan 20;27(1):29. doi: 10.1186/s13054-023-04322-y.
Zotero 插件